Uterine cancer was reduced in the obesity trials
Approximately 50% of MEITL patients require emergency surgical intervention due to advanced-stage presentation of acute small bowel obstruction (SBO)/or perforation, often resulting in peritonitis, septic shock and multiple organ failure
Some patients may experience mild nausea, digestive discomfort, or injection site reactions
In November 2023, the FDA approved a weight loss version of the drug, called Zepbound, which also contains tirzepatide
It is not approved for human or animal consumption, and it should only be handled by qualified professionals conducting controlled scientific research.
Ozempic works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, which collectively reduce appetite and caloric intake